Table 3.
Comparison of Expanded Disability Status Scale (EDSS) and relapses in 50 patients with relapsing-remitting multiple sclerosis after 12 months of treatment with low-dose vitamin D and placebo.
Treatment group | Differences (95% CI) | ||
---|---|---|---|
Vitamin D (n = 25) Mean (SD) | Placebo (n = 25) Mean (SD) | ||
EDSS at 12-months | 1.63 (0.70) | 1.94 (1.41) | −0.31 (−0.94, 0.32) |
Relapses at 12-months | 0.32 (0.48) | 0.40 (0.58) | −0.08 (−0.38, 0.22) |